SCHEMBL3586972

SCHEMBL3586972

N#CCC(=O)c1nc2cc(Cl)ccc2s1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGPAT2 O15120 1/20 0.54
HDAC6 Q9UBN7 1/20 0.50
MEN1 O00255 3/20 0.49
MAPT P10636 3/20 0.49
KMT2A Q03164 3/20 0.49
HSD17B10 Q99714 2/20 0.49
USP2 O75604 1/20 0.49
LMNA P02545 1/20 0.49
HTT P42858 1/20 0.49
PPARA Q07869 7/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
LOXL2 Q9Y4K0 1/20 0.47
ALDH1A1 P00352 2/20 0.46
HPGD P15428 2/20 0.46
NPC1 O15118 1/20 0.46
TSHR P16473 1/20 0.46
RAB9A P51151 1/20 0.46
ALOX5 P09917 4/20 0.46
KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3592984 0.89 DYRK1A (0.48) AGPAT2MEN1MAPTKMT2ALMNA
SCHEMBL24962530 0.80 SMN1; SMN2 (0.57) HDAC6MEN1MAPTKMT2AHSD17B10
SCHEMBL30209129 0.80 SMN1; SMN2 (0.57) HDAC6MEN1MAPTKMT2AHSD17B10
SCHEMBL3594981 0.79 RAB9A (0.63) MEN1MAPTKMT2ALMNAHTT
SCHEMBL30515646 0.79 HDAC6 (0.57) HDAC6PPARASMN1; SMN2NPSR1LOXL2
SCHEMBL3643594 0.79 HDAC6 (0.57) HDAC6PPARASMN1; SMN2NPSR1LOXL2
SCHEMBL11228986 0.79 SMN1; SMN2 (0.54) HDAC6MEN1MAPTKMT2AHSD17B10
SCHEMBL3621185 0.77 HDAC6 (0.56) HDAC6PPARASMN1; SMN2NPSR1LOXL2
SCHEMBL3711953 0.77 SMN1; SMN2 (0.53) HDAC6MEN1MAPTKMT2AHSD17B10
SCHEMBL13808707 0.77 IDO1 (0.56) HDAC6PPARASMN1; SMN2NPSR1LOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023210772-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, PHOTOSENSOR, AND COMPOUND 富士フイルム株式会社 2023-11-02 WO disclosed
US-20100063065-A1 THIOPHENE DERIVATIVES AS PPAR AGONISTS I INPHARMATICA LIMITED (GB) 2010-03-11 US disclosed
EP-1937663-A1 THIOPHENE DERIVATIVES AS PPAR AGONISTS I Inpharmatica Limited (GB) 2008-07-02 EP disclosed
WO-2007036730-A9 THIOPHENE DERIVATIVES AS PPAR AGONISTS I INPHARMATICA LTD (GB) 2008-06-19 WO disclosed
WO-2007036730-A1 THIOPHENE DERIVATIVES AS PPAR AGONISTS I INPHARMATICA LIMITED (GB) 2007-04-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063065-A1 THIOPHENE DERIVATIVES AS PPAR AGONISTS I PPARG, PPARD, PPARA AGPAT2 438/4885HDAC6 876/4885MEN1 4876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.